Research and Markets: Global Relapsed Multiple Myeloma Pipeline Report 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/8w853w/relapsed_multiple) has announced the addition of the "Relapsed Multiple Myeloma - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Relapsed Multiple Myeloma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Relapsed Multiple Myeloma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • 4SC AG
  • AB Science
  • AbbVie Inc.
  • Acceleron Pharma, Inc.
  • Acetylon Pharmaceuticals, Inc.
  • Altor BioScience Corporation
  • Arno Therapeutics, Inc.
  • Array BioPharma Inc.
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Biotest AG
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Immunomedics, Inc.
  • Johnson & Johnson
  • Karyopharm Therapeutics, Inc.
  • MedImmune, LLC
  • Merck & Co., Inc.
  • Millennium Pharmaceuticals, Inc.
  • MorphoSys AG
  • Novartis AG
  • Onyx Pharmaceuticals, Inc.
  • Patrys Limited
  • Pfizer Inc.
  • Pharma Mar, S.A.
  • Pharmacyclics, Inc.
  • Prolexys Pharmaceuticals, Inc.
  • Sanofi
  • Threshold Pharmaceuticals, Inc.
  • Vivolux AB

For more information visit http://www.researchandmarkets.com/research/8w853w/relapsed_multiple

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology